Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial

OBJECTIVE: Intravenous iron—a common treatment for anaemia and iron deficiency due to inflammatory bowel disease (IBD)—can cause hypophosphataemia. This trial compared the incidence of hypophosphataemia after treatment with ferric carboxymaltose (FCM) or ferric derisomaltose (FDI). DESIGN: This rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoller, Heinz, Wolf, Myles, Blumenstein, Irina, Primas, Christian, Lindgren, Stefan, Thomsen, Lars L, Reinisch, Walter, Iqbal, Tariq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086283/
https://www.ncbi.nlm.nih.gov/pubmed/36343979
http://dx.doi.org/10.1136/gutjnl-2022-327897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086283/
https://www.ncbi.nlm.nih.gov/pubmed/36343979
http://dx.doi.org/10.1136/gutjnl-2022-327897

Ejemplares similares